Rapid response to anifrolumab in refractory systemic lupus erythematosus

dc.contributor.author	López-Martínez, Diego
dc.contributor.author	Lozano-Rivas, Nuria
dc.contributor.author	Sánchez-Pedreño-Guillén, Paloma
dc.date.accessioned	2026-03-10T11:53:53Z
dc.date.available	2026-03-10T11:53:53Z
dc.date.issued	2025-09
dc.identifier.citation	López-Martínez D, Lozano-Rivas N, Sánchez-Pedreño-Guillen P. Rapid response to anifrolumab in refractory systemic lupus erythematosus. Medicina Clínica. septiembre de 2025;165(3):107007. doi:10.1016/j.medcli.2025.107007
dc.identifier.issn	0025-7753
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/25330
dc.language.iso	eng
dc.publisher	ELSEVIER ESPAÑA
dc.rights	Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.title	Rapid response to anifrolumab in refractory systemic lupus erythematosus
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	40413848
dc.relation.publisherversion	https://linkinghub.elsevier.com/retrieve/pii/S0025775325002350
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.identifier.doi	10.1016/j.medcli.2025.107007
dc.journal.title	Medicina Clinica
dc.identifier.essn	1578-8989